Nucleus goes public and lists on AIM

Initial value of £140m

clock • 1 min read

Nucleus has listed on the Alternative Investment Market (AIM) at an expected market capitalisation of £140m.

Dealing on the platform company's shares begun at 8am on Thursday at a placing price of 183p. The gross proceeds of the listing receivable by the selling shareholders could be more than £32m.  The firm, which has more than £14bn assets under administration, said 22.9% of the issued ordinary share capital was sold pursuant to the placing. "This is an important milestone as we continue our work to support and promote the strategic alignment of advisers and their customers," said chief executive David Ferguson. "It's great to see so many institutional investors believing in the growth...

To continue reading this article...

Join Investment Week for free

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Investment

Partner Insight: The attractions of the small-mid private equity segment

Partner Insight: The attractions of the small-mid private equity segment

New empirical research from Schroders Capital reveals that small and mid-sized private equity funds have outperformed large funds with greater resilience through economic cycles

Viswanathan Parameswar, Eufemiano Fuentes Perez and Verity Howells at Schroders
clock 19 November 2024 • 4 min read
Partner Insight: Is it time to rebalance portfolios as the UK economy stabilises?

Partner Insight: Is it time to rebalance portfolios as the UK economy stabilises?

Brooks Macdonald
clock 18 November 2024 • 2 min read
Partner Insight: The case for value in a balanced portfolio

Partner Insight: The case for value in a balanced portfolio

It’s been an anemic time for value stocks but the managers of Vanguard’s active multi-asset range think a focus on valuations could be rewarded.

Madison McCall Active Product Specialist, Vanguard, Europe
clock 18 November 2024 • 5 min read
Trustpilot